Biologics for paediatric severe asthma: trick or TREAT?

Lancet Respir Med. 2019 Apr;7(4):294-296. doi: 10.1016/S2213-2600(19)30045-1. Epub 2019 Feb 26.
No abstract available

MeSH terms

  • Acute Disease
  • Adolescent
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma / drug therapy*
  • Biological Products / therapeutic use*
  • Child
  • Humans
  • Omalizumab / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Omalizumab
  • benralizumab
  • mepolizumab